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ABSTRACT 
INTRODUCTION 
Origin of cytology dates back more than a century, for over 100 years the 
discipline of anatomical pathology, has centred on diagnostic histopathology.  
 Diagnostic cytology is the science of interpretation of cells derived from 
human body, which either exfoliates freely from epithelial surface or removed 
from various sources by artificial means. 
 A correct diagnosis helps in starting the specific therapy in time, thus 
reducing morbidity and mortality. Imprint and Scrape cytology are now rapid 
diagnostic tool in the armamentarium of clinician’s .Imprint and scrape 
cytology are simple and rapid techniques for diagnosis. 
           Imprint is a touch preparation in which tissue is touched on the slide and 
it leaves behind its imprint in the form of cells on glass slide; studies are made 
after proper staining. 
         Scrape cytology is performed by using sterile sticks on the lesion and 
studies done after slides prepared with staining 
          This study is undertaken with the aim that though biopsy is Gold 
standard, imprints and scrape cytology are a rapid, simple and easy technique 
for tissue diagnosis. This is an accurate diagnostic tool available to all 
practicing surgeon even in small hospitals and semi urban hospitals 
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AIMS & OBJECTIVES 
To analyze the sensitivity and specificity of imprint and scrape cytology 
and thereby to evaluate its diagnostic utility in comparison with biopsy results. 
MATERIALS AND METHODS 
1. SOURCE OF DATA  
 2. TYPE OF STUDY 
 3. NUMBER OF GROUPS STUDIED 
 4. SAMPLE SIZE 
 5. INCLUSION CRITERIA 
 6. EXCLUSION CRITERIA 
 7. PARAMETERS STUDIED 
 8. PROCEDURE  
 9. METHOD OF STATISTICAL ANALYSIS 
 10. ETHICAL CONSIDERATIONS 
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SOURCE OF DATA 
All patients admitted to the Department of General Surgery with clinical 
evidence of Surface malignancies 
These patients were subjected to Imprint/Scrape cytology and biopsy of 
clinically suspicious Lesions . 
Accuracy of Imprint /Scrape cytology results compared with Histopathology. 
 
TYPE OF STUDY 
COMPARISON  STUDY 
 
NUMBER OF GROUPS STUDIED 
Patients admitted with clinically evident surface malignancies in the 
Department of General Surgery in Government Thanjavur Medical College 
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SAMPLE SIZE 
This study was carried out on 50 patients admitted with Clinically evident 
surface malignancies for a period of one year from September 2016  to  
September 2017 
 
 
INCLUSION CRITERIA 
All patients with the following Surface malignancies 
Ca Buccal mucosa , Lip, Tongue 
Ca Breast with ulceration 
Ca Rectum and anal canal 
Malignant cutaneous ulcers 
Ulcerated neck swelling 
EXCLUSION CRITERIA 
Patients not willing for study 
Patients with Gynaecological malignancies like Ca Vagina and Ca Vulva 
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PARAMETERS STUDIED 
All patients admitted to the Department of General Surgery with clinical 
evidence of Surface malignancies after relevant history and clinical 
examination. These patients were subjected to Imprint/Scrape cytology and 
biopsy of clinically suspicious Lesions  after informed consent. Comparison of 
results by statistical analysis done. Accuracy of Imprint /Scrape cytology results 
compared with Histopathology. 
 
PROCEDURE  
All patients admitted to the Department of General Surgery with clinical 
evidence of Surface malignancies after relevant history and clinical 
examination. 
These patients were subjected to Imprint/Scrape cytology and biopsy of 
clinically suspicious Lesions  after informed consent. 
sterile blade; 
          sterile gloves 
          sterile sticks 
          clear glass slides 
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          glass marking pencil 
          sterile dressing material 
 
 
Technique for imprint smear: 
The imprints were prepared according to technique described by Tribe. 
 Slides properly labelled by glass marking pencil. 
 Slides were touched on the  surface of the lesion , avoiding a gliding 
movement. Pressure applied for imprinting varied with the consistency of 
the specimen. 
 Smears were quickly fixed in 95% alcohol in order to avoid air drying 
artefact and stained with a variant of Papanicolaou’s-stain. 
 
Technique for Scrape smear: 
 As ulcers are typically covered with a haematic crust containing 
inflammatory– necrotic cells or debris,  the first scrapes must be carried 
out to remove the superficial debris and after these, other scrapes were 
gently performed to collect more representative specimens. 
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 Multiple delicate scrapings were repeated to gradually reach the bottom 
of the ulcer without excessive bleeding  using edge of the glass 
slide/wooden spatula. 
 Smears were quickly fixed in 95% alcohol 
Biopsy specimens taken from these patients  fixed in 40% formalin. After 
proper fixation samples were processed by routine histopathological processing 
and sections were stained by Hematoxylin and Eosin 
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THE PROFORMA FOR STUDY:  
Name: 
Age/Sex: 
Clinical diagnosis: 
Imprint cytology: 
Scrape cytology: 
Biopsy report: 
Comparison of results by statistical analysis done: 
Accuracy of Imprint /Scrape cytology results compared with Histopathology: 
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METHOD OF STATISTICAL ANALYSIS: 
 AGE DISTRIBUTION 
 CASE DISTRIBUTION 
 SENSITIVITY 
 SPECIFICITY 
 POSITIVE PREDICTIVE VALUE 
 NEGATIVE PREDICTIVE VALUE 
 
ETHICAL CONSIDERATIONS: 
 Consent obtained from the patients after assuring the non harmfulness 
and confidentiality of the study 
 Patients  are  assured that the details of the study were only used for 
academic purpose 
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                               REVIEW OF LITERATURE 
Rapid and accurate diagnosis is of paramount importance in the outcome 
of medical care. Though the histopathology remains the gold standard , the 
imprint /scrape cytology is one of the rapid  methods that can be used in the 
diagnosis of benign and malignant lesions in shorter period. A correct diagnosis 
helps in initiating the specific therapy in time, thus reducing morbidity and 
mortality. Histopathology is the gold standard means of establishing a definitive 
pathological diagnosis, whereas use of cytology is controversial.  In present 
study we have correlated the cytological diagnosis by imprint/scrape cytology 
with histological diagnosis and tried to evaluate the accuracy and usefulness of 
this method. 
For centuries, tissue diagnosis was restricted to macroscopic examination of  
 
autopsy material and a limited range of surgical specimens. Microscopic  
 
examination of human tissue from autopsies and surgical procedures was  
 
introduced in the nineteenth century. Analysis of tissue samples is now an  
 
integral part of clinical management. Tissue diagnosis is usually the  
 
responsibility of a histopathologist (or ‘pathologist’), who is a medically  
 
qualified practitioner. The specialty now known as histopathology (or  
 
sometimes cellular pathology) encompasses histopathology, cytopathology and  
 
autopsy work and is heavily dependent on microscopy. 
 
 
In the UK, the nature of the histopathologist’s work has changed since the  
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1960s. There has been a steady increase in biopsy numbers, partly because of  
 
flexible endoscopy. Many resection specimens are assessed with management  
 
and prognosis in mind, the diagnosis having been made preoperatively. 
 
Screening programmes have had a major impact. New techniques have  
 
improved the quality and value of histopathological assessment, while autopsies  
 
have steadily decreased in number. Published minimum standards for the  
 
assessment of a specimen,e.g. a cancer resection, are often in place. In addition,  
 
histopathologists are increasingly involved in multidisciplinary patient  
 
management meetings. 
 
 
A modern histopathology department is usually located in a medium-sized or  
 
large hospital. Typically, more than 80 per cent of specimens are from the  
 
gastrointestinal tract, gynaecological tract or skin. In line with clinical services,  
 
highly specialised work, e.g. neuropathology, is confined to major regional  
 
centres. 
 
 
REASONS FOR ASSESSMENT OF TISSUE 
 
A new diagnosis may be made, e.g. squamous cell carcinoma, or a known  
 
diagnosis confirmed. Microscopic clues may be found, e.g. granulomatous  
 
inflammation. Additional expected or unexpected diagnoses may be made. For  
 
example, biopsies from a patient with inflammatory bowel disease are taken to  
 
confirm the diagnosis and exclude dysplasia but might reveal additional 
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findings, e.g. cytomegalovirus. An appendix removed for appendicitis could  
 
contain an incidental carcinoid tumour. Tissue analysis also helps to determine  
 
treatment and prognosis. For example, a liver biopsy from a patient with chronic  
 
viral hepatitis is not taken to make the diagnosis but instead helps to determine 
 
therapy, exclude other diseases (e.g. steatohepatitis) and exclude complications  
 
of chronic liver disease (e.g. neoplasia). 
 
 
The pathologist’s assessment of resections also helps surgeons to audit their  
 
performance. A tissue sample does not necessarily represent the entire patient.  
 
The interpretation of microscopic changes may be considerably enhanced by  
 
correlation with the macroscopic findings and the clinical picture. Accordingly,  
 
a request form with adequate clinical details should accompany all specimens.  
 
Essential details include site of biopsy, date of birth, gender, medications,  
 
relevant risk factors and past medical history. 
Summary box 15.1 
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HISTOLOGY 
 
Specimens for histology are arbitrarily classified as biopsies and resections,  
 
although the word ‘biopsy’ can refer to any tissue sample. Types of biopsy  
 
include punch biopsy, needle core biopsy and mucosal biopsy. An excision  
 
biopsy serves as both a diagnostic biopsy and a small resection. Samples for  
 
routine histology are immediately placed in a fixative, usually formalin 
 
(10 per cent formaldehyde), to preserve morphology. 
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CYTOLOGY 
 
Cytological specimens can be obtained from many sites using a variety of  
 
approaches. Some are easy to obtain, e.g. urine and sputum, whereas others  
 
require more intervention. A conventional cervical smear is obtained by  
 
sampling the cervical transformation zone with a brush/broom. Bronchial  
 
aspirates, washings and brushings, and gastrointestinal and biliary brushings 
 
sample a relatively wide area and may therefore be useful for the diagnosis of  
 
neoplasia. Fine-needle aspiration (FNA) cytology may sample accessible sites  
 
such as the breast, thyroid and superficial lymph nodes, while FNA from deeper  
 
and less accessible structures, e.g. liver, pancreas, kidney and lung, is usually 
 
assisted by ultrasound or computed tomography (CT) guidance. Ultrasound- 
 
guided transbronchial FNA may be used for mediastinal masses and  
 
transmucosal FNA for submucosal gastrointestinal lesions or perivisceral  
 
lesions. Fluids may be submitted directly to the laboratory for cytological  
 
assessment. 
 
 
 
FRESH TISSUE 
 
 
The most common indication for submission of a fresh tissue sample (i.e.  
 
without fixative) is rapid frozen section diagnosis, but other indications are  
 
microbiological assessment, electron microscopy, chemical analyses (e.g.  
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quantification of iron) and various types of molecular pathological analysis.  
 
Before fixing a histology or cytology specimen, the operator should ask whether 
 
any of these investigations might be useful. 
 
 
RISK MANAGEMENT 
 
 
Safety and risk management are priorities in the laboratory. Any risk of  
 
contamination by transmissible infection, e.g. hepatitis B virus, HIV, must be  
 
minimised by the use of warning labels, especially when fresh tissue is being  
 
submitted. Formalin kills many micro-organisms, but any risk of infection  
 
should still be notified. Also, formalin itself is toxic to the eyes and skin. 
 
 
Accordingly, leaking or faulty specimen containers should be discarded.  
 
Containers must be labelled with the patient’s details to avoid errors of identity 
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SPECIMEN PROCESSING 
 
Histology specimen 
 
On arrival in the histopathology department, specimens are given a unique  
 
number and submitted for macroscopic assessment and sampling (‘cut up’). The  
 
largest specimens are opened (e.g. bowel) or sliced (e.g. uterus) and left to fix in  
 
formalin for at least 1 day. Once fixed and in a suitable condition for cutting, a  
 
text description of the specimen and any visible lesion is made. Representative  
 
samples (‘blocks’) are taken from any specimen too large to be processed  
 
whole. This is usually done by a histopathologist, especially if a case is  
 
complex, but sometimes by non-medical staff. A local or national protocol for  
 
sampling is often followed. For example, samples from most types of cancer  
 
include resection margins, tumour, lymph nodes, non-neoplastic tissue, and any  
 
other abnormal areas. Coloured inks may be used to identify resection 
 
margins and surfaces. 
 
 
Specimens, or samples from specimens, are placed in plastic cassettes and then  
 
embedded in paraffin wax while in the cassette to make a tissue block. 
 
Sections with a thickness of approximately 5 μm (microns) are 
 
cut from the block using a microtome. The sections are placed on a glass slide  
 
and stained with haematoxylin and eosin (H&E). This work is done by trained 
 
staff, known in the UK as biomedical scientists (BMSs). High standards are  
 
necessary because a poorly cut section may have various artefacts, such as lines  
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and folds, which impede accurate assessment. H&E as the first line stain has  
 
stood the test of time, probably because it is inexpensive, safe, fast, reliable,  
 
familiar and informative. 
 
 
The stained sections are examined with a microscope by a histopathologist, who  
 
correlates the histological features with the clinical details and with the  
 
macroscopic description. 
 
  
 
 
Cytology specimen 
 
Many samples for cytology can be smeared immediately onto glass slides, fixed  
 
(usually in alcohol) or air dried, and stained immediately or later. Several slides  
 
are usually produced, some of which are stained with a Papanicolaou (Pap) stain  
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and some with another method such as May–Grünwald–Giemsa (MGG) 
 
or Romanowsky. Pap stain is regarded as the preferred stain for fixed specimens  
 
while MGG is better for air-dried material. Often the sample will be stained  
 
with both. Cervical smears are usually stained with a Pap stain only. There has  
 
been a move towards liquid-based thin-layer technology for many samples. For  
 
liquid-based cytology, the sampling device is usually washed in a liquid  
 
medium and the material obtained is then processed in the laboratory.  
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PERINEURAL INVASION 
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VASCULAR INVASION 
 
 
 
NUCLEAR PLEOMORPHISM 
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CAUSES OF FALSE-POSITIVE DIAGNOSES OF MALIGNANCY 
 
 Interchanged samples 
 
 Contamination 
 
 Interpretative error 
 
 Treatment-induced change 
 
ASSESSMENT 
 
 
Light microscopy 
 
Most tissue assessment depends on conventional light microscopy. Microscopes  
 
have several lenses with various powers of magnification, typically ranging  
 
from ×20 to ×400 or more. A low-power lens allows a sample to be scanned and  
 
its overall architecture to be assessed, while a high-power lens allows a 
 
closer and more detailed view. A teaching arm and a camera can be attached to  
 
most microscopes. Polarisation can be used to detect foreign material (e.g.  
 
sutures) or to assess a special stain (e.g. Congo red). 
 
 
Histological assessment 
 
In a histological preparation, the microscopic structure of the tissue is  
 
preserved, allowing direct visualisation of architecture. Accordingly, the  
 
pathologist can see not only the characteristics of the cells that form the tissue,  
 
but also the way in which these cells are related to one another and the way in  
 
which different tissue compartments are arranged. 
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Cytological assessment 
 
A cytological preparation consists of a sample of cells. Architecture cannot be  
 
determined, because intact tissue is absent or sparse. Therefore, assessment  
 
relies mainly on the characteristics of the cells themselves. Accordingly, it may  
 
be difficult to diagnose malignancy because many of the criteria, particularly  
 
invasiveness, cannot be assessed. However, cytology has several potential  
 
advantages over histology. A wider area may be sampled, and obtaining a  
 
specimen may be easier and less traumatic. Processing times are usually shorter  
 
and costs lower.  
 
 
Screening 
 
Screening programmes aim to detect and treat pre-malignant tissue changes, e.g.  
 
dysplasia, or early stage malignancy (rather than advanced disease). They may  
 
rely on cytology, histology or both. The largest is the cervical cancer  
 
programme, which uses cytology initially, with biopsy and histology follow up  
 
if appropriate. The breast cancer screening programmes may use cytology  
 
and/or histology, while the bowel cancer screening programmes and screening  
 
for cancer in ulcerative colitis rely on histology. 
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SPECIAL STAINS 
 
A ‘special stain’ is a stain that is not routine. Immunohistochemical stains are  
 
conventionally excluded from this category. Some special stains demonstrate  
 
normal substances in increased quantities or in abnormal locations. The periodic  
 
acid–Schiff (PAS) stain demonstrates both glycogen and mucin, whereas a  
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diastase periodic acid–Schiff (D-PAS) stain demonstrates mucin, e.g. in 
 
an adenocarcinoma.  Perls Prussian blue stain demonstrates iron 
 
accumulation , e.g. in haemochromatosis.  A reticulin stain helps to demonstrate  
 
fibrosis. Elastic stains also show fibrosis and can highlight blood vessels by  
 
outlining their elastic laminae. Special stains can also reveal the accumulation  
 
of abnormal substances, e.g. a Congo red stain for amyloid. 
 
 
 
IMMUNOHISTOCHEMISTRY 
 
 
Immunohistochemistry, which was introduced in the 1970s, has had a major  
 
impact on histopathological diagnosis. This technique detects a specific antigen  
 
using an antibody. The antibody is labelled with a dye and when bound to its  
 
target antigen is seen in the tissue section as a coloured stain, often 
 
brown. This allows the presence, tissue distribution and cellular localisation of  
 
an antigen to be determined. Immunohistochemistry can be applied to fixed and  
 
frozen tissue and to cytological preparations. It is specific, safe, quick and  
 
relatively inexpensive. However, false-positive results can result from non- 
 
specific staining or from crossreaction with similar antigens. 
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 SCRAPE/IMPRINT TISSUE BIOPSY 
MATERIAL Cells Tissue 
COST Minimal Expensive 
ANAESTHESIA Not necessary May be necessary 
EQUIPMENT Minimal Extensive 
SAMPLING ERROR Possible Rare 
COMPLICATIONS Rare Uncommon 
HOSPITAL 
ADMISSION  
Outpatient procedure May need admission in 
the hospital 
ANCILLARY STUDIES Possible Possible 
 
 
ELECTRON MICROSCOPY 
 
Electron microscopy allows tissue to be visualised at very high magnification,  
 
e.g. ×1000 to ×500 000. It may help to decide the lineage of a non-neoplastic or  
 
neoplastic cell in difficult cases, and may help to determine the nature of  
 
abnormal deposits, e.g. in renal disease. Unfortunately, it is time-consuming,  
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labour intensive and expensive, and is now used very selectively. 
 
 
IN SITU HYBRIDISATION 
 
In situ hybridisation (ISH) uses a labelled oligonucleotide probe targeted at a  
 
specific RNA or DNA sequence. It can be performed on fixed or fresh tissue  
 
sections, allowing the presence or absence of a particular sequence and its  
 
location to be determined. Viral genomes, e.g. EBV, CMV and human  
 
papillomavirus, can be detected using this approach. 
 
 
INTERPHASE CYTOGENETICS 
 
This technique is relatively safe and fast and has largely replaced conventional  
 
cytogenetics for the analysis of chromosomal changes. It relies mainly on  
 
fluorescent in situ hybridisation (FISH) (named after the probe’s fluorescent  
 
label), but also silver in situ hybridisation (SISH) and other methods. Fresh 
 
and fixed histological material and cytological preparations can be used, the  
 
latter typically yielding better results. The probe can target centromeres in order  
 
to assess numerical or structural chromosomal abnormalities or can target  
 
specific genes. 
 
 
The technique is used (alongside immunohistochemistry) to detect HER2  
 
amplification in breast cancer and, more recently, in advanced gastric cancer.  
 
The results inform the selection of therapy. Other uses include detection of  
 
chromosomal gains, losses, and translocations in tumours (e.g. haematological  
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malignancies) and non-neoplastic conditions (e.g. trisomy 23) and 
 
loss of specific gene regions in tumours (e.g. 1p and 19q in   
 
oligodendrogliomas).  
 
 
POLYMERASE CHAIN REACTION-BASED AND RELATED  
 
TECHNIQUES : 
 
 
The PCR amplifies DNA, yielding millions of copies from a single copy of a  
 
selected target. The amplified DNA is detected using various techniques, e.g.  
 
electrophoresis. RNA can also be amplified, using the technique of reverse  
 
transcriptase polymerase chain reaction (RT-PCR). PCR is highly sensitive, fast 
 
and safe. However, it is expensive and has a high chance of contamination with  
 
DNA from outside sources. PCR can be performed on non-tissue samples (e.g.  
 
peripheral blood) and on homogenised fresh tissue. DNA or RNA extracted  
 
from formalin fixed tissue may be of lower quality but is also widely used. PCR 
 
has many clinical applications, particularly the detection of gene mutations and  
 
amplifications and the confirmation of clonality in tumours. 
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IMPRINT CYTOLOGY 
The technique of imprint cytology has provided great impetus to 
cytodiagnosis due to its simplicity, cost effectiveness, rapid results. 
Points to improve the accuracy : 
The tissue surface to be imprinted should be flat and there should be no 
portion of fat protruding from the edges as these tend to smudge the imprint. 
2. Sometimes the first imprint contains excess tissue fluid and blood and it was 
found that subsequent imprints give better cytological results. 
3. The ease with which any tumor gets imprinted varies considerably. In order 
to obtain imprint smears of one cell thickness, the amount of pressure applied at 
the time of imprinting varies. Benign looking lesions usually require more 
pressure in order to obtain sufficient cells for diagnosis while malignant tumors 
get imprinted more easily. 
4. Malignant tissue imprints were more cellular than those of benign looking 
lesions. 
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Advantages 
(1) The procedure for imprint cytology can be done even with poor  
infrastructure. 
(2) Analysis of an individual cell is performed by imprint cytology.  It 
provides an immediate result with minimal artifacts,  It is cheaper and so 
it is most commonly used. 
(3) A precise diagnosis is received through this technique. 
 
Disadvantages 
The depth of infiltration cannot be analyzed with imprint cytology. 
Tumors and well-differentiated tumors with dense fibrous stroma cannot be 
interpreted through this method. 
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                       SURFACE MALIGNANCIES STUDIED 
ORAL MALIGNANCIES 
 The Oral cavity extends from vermillion border of lips to plane between 
junction of hard palate and soft palate which includes :Buccal mucosa, 
upper and lower alveolar ridges ,oral tongue, gingiva, retromolar trigone, 
floor of mouth, hard palate 
 Oral malignancies account for 40% of Head and Neck cancer and ranked           
eighth among the most common malignancies in the world. The age of 
onset is around 6
th
 -7
th
  decade . High incidence is seen in India, SE Asia. 
 In India ,20 Per 100000 population are affected by oral cancer which 
accounts for about 30% of all types of malignancies. Around 5 people in 
india die everyday due to oral malignancy. 
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PREMALIGNANT LESIONS : 
Erythroplakia - non-inflammatory erythematous plaque 
Lip, tongue, or floor of the mouth lesions are prone for progression to SCC 
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 Leukoplakia - chronic, white, verrucous plaque with histologic atypia 
5 - 10 % progress to SCC 
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 Submucous fibrosis-generalized white discoloration of oral mucosa with 
progressive fibrosis leading to painful mucosal atrophy and restrictive 
fibrotic bands which ultimately results in trismus, dysphagia and severe 
xerostomia 
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CANCEROUS LESION OF  ORAL CAVITY: 
                      SCC 90% 
 
Lips –SCC, Melanoma, BCC(rare) <5% low grade, slow growing rarely  
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metastasizes with tendency to invade deep tissue. 
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ETIOLOGY 
 
             About 90% of people with oral cavity and oropharyngeal cancer use 
tobacco and  tobacco products. Drinking alcohol strongly increases a smoker’s 
risk of developing oral cavity and oropharyngeal cancer. More than 30% of 
patients with cancers of the lip have outdoor occupations associated with 
prolonged exposure to sunlight. Long-term irritation to the lining of the mouth 
caused by poorly fitting dentures and sharp teeth 
 
Risk Factors 
 Poor nutrition: A diet low in fruits and vegetables is associated with an 
increased risk 
 Age: The likelihood of developing oral and oropharyngeal cancer 
increases with age, especially after age 35 
 Gender: Oral and oropharyngeal cancer is twice as common in men as in 
women 
 Immunocompromised people 
 Human papillomavirus (HPV) infection: Commonly affects younger 
age groups , male, non smokers. High risk HPV-16 predominate type. 
Association strongest for Oropharynx, specially cancer of tonsils 
followed by base of tongue. 
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INHERITED RISK FACTORS are  
 
Tumor suppressor gene(p53) defect: Li Fraumeni syndrome. 
Defective DNA repair mechanism: Xerodermapigmentosa, ataxia 
telangiectasia, bloom syndrome, fanconi syndrome. ABO blood groups :Blood 
group A had 1.46 times higher risk of developing oral cancer as compared with 
other blood group. 
 
 
COMMON SITES are  
Lips: lower-93%, upper-5%, commissure- 2%
 
RMT: 2% 
Upper alveolus/hard palate: 8% 
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Buccal mucosa: 10% 
Lower alveolus: 15% 
Floor of mouth: 30% 
 
 
Tongue : 35% 
Patient need the following Investigations: for staging- CT neck ± CT 
chest- MRI- USG of neck or primary ± USG guided FNAC of suspicious 
lymphadenopathy 
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STAGING OF THE DISEASE : 
TNM STAGING - 
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Treatment goals:  
To eradicate primary tumor and LN metastasis,  
Reconstruction to maintain form and function 
 
TUMOR FACTORS AFFECTING TREATMENT 
The  prognosis depends on the site, size(T stage), location, multiplicity, 
histology, grade, depth of invasion, pathological features, Status of cervical 
lymph nodes Proximity to bone 
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TREATMENT 
The  Mainstay of  treatment for oral malignancies is surgical management: 
Wide local excision+/- Chemoradiotherapy 
Surgical approach depends on the tumor size, tumor site ,proximity to mandible 
or maxilla ,Need for neck dissection ,Need for reconstructive surgery. 
Chemotherapy drugs commonly used are cisplatin, carboplatin, 
5flurouracil,paclitaxel,docetaxel. 
Immunotherapy commonly given include IL 2/IRX 2,BCG vaccine 
Targeted therapy 
Anti-EGFR MoAbs : cetuximab , pantimumab, zalutumumab 
EGFR targeted tyrosine kinase inhibitors: gefitinib, erlotinib 
 EGFR & HER-2 combined tyrosine kinase inhibitors: lapatinib, BIBW-2992. - 
VEGFR inhibitor: bevacicumab, sorafenib, sunitinib 
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MALIGNANT SKIN TUMOURS  
Malignant skin tumors most commonly arises from the epidermis  
 TYPES 
Basal cell carcinoma  
Squamous cell carcinoma  
Malignant melanoma  
Skin adnexal tumors are rare  
Chemical carcinogens play a major role 
Basal cell carcinoma (RODENT ULCER) 
Basal cell carcinoma (BCC) is a malignant tumour of the skin arising from basal 
cells in the epidermis. BCCs are very common slow growing tumours,locally 
invasive particularly in those exposed to ultraviolet light. They usually appear 
after the age of 50  90% are found on the forehead, face and hair margin. 
Clinical findings: 
BCCs present as small nodules that soonbecome ulcerated centrally, producing 
an umbilicated lesion.A history of a lesion that apparentlyheals only to recur 
soon. As the lesion progresses large areas of ulceration with slightly raised 
pearly coloured edges develop. Untreated, large areas of the face may be eaten 
away with invasion of bone and Cartilage. BCCs do not ,however, metastasize. 
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The diagnosis is made clinically but if there is any doubtbiopsy may be obtained 
prior to definite treatment. 
             
 
                    
 
 
TYPES 
 Nodulocystic - Waxy , cream coloured with rolled, pearly borders 
surrounding central ulcer 
 Morpheaform -Type IV collagenase and spread rapidly.Flat, plaque like 
lesion 
 Basosquamous variant - Highly aggressive. Metastasize similar to SCC 
and aggressive treatment required  
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If the size of the lesion is more than 2cm,the risk of  Basal cell carcinoma 
is more. Specific location are nose ,ear, eyes. margins are usually  
Ill-defined and they are more prone for recurrence. 
Management of BCC 
 Surgery is the mainstay of treatment which involves  Complete 
tumor removal , with pathological confirmation and margin 
analysis. Large tumors invading adjacent structure with 
aggressive histology needs WIDE LOCAL EXCISION with 1cm 
margin.  
 MOHS Micrographic Surgery Excision of skin cancer under 
microscopic control. Minimise recurrent rates with maximum 
conservation.  
 Poorly demarcated lesions, lesions located Near vital structures , 
Recurrent / incompletely excised, Can also be used for squamous cell 
carcinoma, lentigomaligna. 
Non Surgical management consists of laser vapourisation, 
electrodessication, Curettage 
Other Modalities: Topical treatments,Cryotherapy,Imiquimod,5-
fluorouracil and  Radiotherapy also plays an important role. 
Squamous cell carcinoma 
Squamous cell carcinoma (SCC) of the skin arises fromthe keratinocytes in the 
epidermis. It grows rapidly with anaplasia, local invasion and metastases.  
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Solar keratoses and Bowen's disease are precursors of SCC of the skin . 
 SCC also occurs mostly on the exposed areas ofthe body (75% on the head, 
15% on the hands)  
 These are aggressive tumours thatwill invade the structures deep to the dermis 
with metastasesto regional lymph nodes . 
Establishing the diagnosis is the first step in the management 
of SCC. This is done by obtaining a biopsy forhistological diagnosis 
Microscopic Appearance  
KERATIN PEARLS - Irregular masses of squamous epithelium proliferate and 
invade dermis . Perineural / vascular invasion. Positive for cytokeratin 1 and 
10Border’s histological grading-Ratio of pleomorphic and anaplastic to normal 
cells 
Prognosis 
Perineural and vascular involvement. Invasion - Surface size> 2cm 
 Depth – deeper lesion , worse the prognosis  
Lips and ears – increase recurrent rate Histological grade> Immunosuppression  
TNM Classification  
Size 
 • T1 - <2cm • T2 - 2-5 cm • T3 - >5cm • T4 - muscle or bone involvement 
Nodes  
• N0 - no regional nodes • N1 - regional nodes  
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Metastasis • M0 - no metastasis • M1- distant metastasis  
Grade • G1- low grade • G2moderately differentiated • G3- high grade 
Surgical excision -Accurate histology.Margins to be assessed  
< 1 cm clearance for lesions >2cm.<4cm lesion – 2cm clearance  
Veruccus carcinoma - Radiotherapy resistant  
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Malignant melanoma 
Malignant melanoma is a malignant tumour arising from 
the melanocytes wherever melanocytes exist leptomeninges Retina  Bowel 
mucosa, melanoma can occur. Approximately 50% of all melanomas 
arise in pre-existing naevi and exposure to intense ultraviolet 
radiation from sunlight is the most important 
aetiological factor. Fair-skinned people 
are affected most often. 
Types Of Malignant Melanoma 
1.Superficial spreading   
2.Nodular melanoma  
3.Lentigomaligna melanoma 
 4.Acrallentiginous melanoma  
5.Amelanotic melanoma  
6.Desmoplastic melanoma 
 
Superficial Spreading Melanoma  
Commonest type – 70%  
Arise from pre – existing nevus  
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Rapid growth of darker pigmented are in a junctional nevus. 
Predominantly radial growth phase. 
Nodularity can occur in vertical growth phase. 
 
Nodular Melanoma  
More aggressive  Common in Middle age men 
Sharply demarcated, blue-black papules 1-2cm.Usually trunk.Middle age men 
Increased vertical growth than radial phase. 
Lack horizontal growth phase 
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CA BREAST 
It is the second most common cancer in women in India. 
 
PREDISPOSING FACTORS are  
 
Genetic 
BRCA1, BRCA2, P53, HNPCC, AT 
 
Hormonal factors : Early menarche, late menopause, hormone replacement 
therapy (> 10 years), nulliparity, Late first birth 
 
Familial 
 First-degree relative with breast cancer under 40 years old 
 Two first-degree relatives with breast cancer under 60 years 
 Three first-degree relatives with breast cancer at any age 
 First-degree relative with breast and ovarian cancer 
 First-degree relative with bilateral breast cancer 
 
Histological types 
The majority (85%) of breast cancer is Invasive Ductal Cancer. 
Ductalcarcinoma can be graded from 1 to 3  
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Grade 1- well differentiated, low grade 
Grade 2 – Moderately differentiated 
Grade 3 -  poorly differentiated, high grade on 
the basis of a grading system originally described by  Bloom and Richardson 
and modified by Elston and Ellis from Nottingham. 
This grading system is based on 
 Tubule formation 
  Mitotic index  
  Differentiation/nuclear pleomorphism 
Correlates with tumour outcome. 
 
Lobular carcinoma accounts for about 10% of breastcancers. It is characterized 
by small round cells infiltratingthe lobule and is often missed on cytology, as 
the cells can be difficult to differentiatefrom normal epithelial cells .Clinically, 
lobularcancer tends to be 
 Multifocal within the breast  
 Bilateral.  
A small percentage of breast cancers belong to special types 
 Medullary (lymphocytic infiltration, better prognosis) 
  Colloid  
  Mucinous, 
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 Tubular. 
 Theseare usually towards the well-differentiated end of the spectrum 
and consequently have a better prognosis. 
 
Invasive ductal carcinoma 
 
 
Invasive lobular carcinoma. 
Clinical features : 
 breast lump (in postmenopausal women all new lumps represent malignancy), 
 bloody nipple discharge, skin changes such as tethering or nipple 
eczema(Paget's disease) , mammographic screening abnormalities.  
If neglected breast cancer may ulcerate through the skin of the breast 
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ULCERATIVE LESION OF BREAST: 
 
 
Triple assessment. 
 Physical examination 
 Radiological assessment 
o Ultrasound in patients under 35 years old 
o Mammography in patients over 35 years old 
 Pathological assessment 
Fine-needle aspiration cytology 
The cells are classified as follows: 
Cl, inadequate  
C2normal/benign 
C3, atypia probably benign                         
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C4, atypia probably malignant; 
C5, malignant 
When cytology is unhelpful the next step 
 Trucut biopsy 
Advantages over  FNAC : 
If a lump is malignant, Histological assessment of tumour grade oestrogen 
receptorstatus can also be assessed 
MALIGNANT CYTOLOGY: 
 
Core biopsy histology showing IDC: 
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TNM classification 
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MANAGEMENT : 
I. Surgery  
II.  Radiotherapy 
III.  Hormone Therapy 
IV.  Chemotherapy 
 Multi-pronged approach adopted  
 
SURGICAL APPROACH consists of 
MASTECTOMY is indicated for large tumours (in relation to the size of the  
 
breast), central tumours beneath or involving the nipple, multifocal disease,  
 
local recurrence or patient preference. The radical Halsted mastectomy, which  
 
included excision of the breast, axillary lymph nodes and pectoralis major and  
 
minor muscles, is no longer indicated as it causes excessive morbidity with no  
 
survival benefit. The modified radical (Patey) mastectomy is more commonly  
 
performed and is thus described below. 
 
 
Simple mastectomy involves removal of only the breast with no dissection of  
 
the axilla, except for the region of the axillary tail of the breast, which usually  
 
has attached to it a few nodes low in the anterior group. 
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PATEY MASTECTOMY 
 
 
The breast and associated structures are dissected en bloc and the excised mass  
 
is composed of : 
 
• the whole breast; 
 
• a large portion of skin, the centre of which overlies the tumour but which  
 
  always includes the nipple; 
 
• all of the fat, fascia and lymph nodes of the axilla. 
 
 
The pectoralis minor muscle is either divided or retracted to gain access to the  
 
upper two-thirds of the axilla. The axillary vein and nerves to the serratus  
 
anterior and latissimus dorsi (the thoracodorsal trunk) should be preserved. The  
 
intercostal brachial nerves are usually divided in this operation and the patient 
 
should be warned about sensation changes postoperatively. The wound is  
 
drained using a wide-bore suction tube. Early mobilisation of the arm is  
 
encouraged and physiotherapy helps normal function to return very quickly;  
 
most patients are able to resume light work or housework within a few weeks. 
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CONSERVATIVE BREAST CANCER SURGERY 
 
 
This is aimed at removing the tumour plus a rim of at least 1 cm of normal  
 
breast tissue. This is commonly referred to as a wide local excision. The term  
 
lumpectomy should be reserved for an operation in which a benign tumour is  
 
excised and in which a large amount of normal breast tissue is not resected. A  
 
quadrantectomy involves removing the entire segment of the breast that 
 
contains the tumour. Both of these operations are usually combined with  
 
axillary surgery, usually via a separate incision in the axilla. There are various  
 
options that can be used to deal with the axilla, including sentinel node biopsy,  
 
sampling, removal of the nodes behind and lateral to the pectoralis minor (level  
 
II) or a full axillary dissection (level III). 
 
 
There is a somewhat higher rate of local recurrence following conservative  
 
surgery, even if combined with radiotherapy, but the long-term outlook in terms  
 
of survival is unchanged. Local recurrence is more common in younger women  
 
and in those with high-grade tumours and involved resection margins. Patients 
 
whose margins are involved should have a further local excision (or a  
 
mastectomy) before going on to radiotherapy. Excision of a breast cancer  
 
without radiotherapy leads to an unacceptable local recurrence rate. 
 
The role of axillary surgery is to stage the patient and to treat the axilla. The  
 
presence of metastatic disease within the axillary lymph nodes remains the best  
 
single marker for prognosis; however, treatment of the axilla does not affect  
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long-term survival, suggesting that the axillary nodes act not as a ‘reservoir’ 
 
for disease but as a marker for metastatic potential. It used to be accepted that  
 
only premenopausal women should have their axilla staged by operation as  
 
there was a good case for giving chemotherapy to lymph node-positive patients;  
 
however, it is now clear that postmenopausal women also benefit from  
 
chemotherapy and so all patients require axillary surgery. In postmenopausal 
 
patients, tamoxifen was once given regardless of axillary lymph node status, but  
 
it is now known that only hormone receptor-positive patients, irrespective of  
 
age, benefit from this. Axillary surgery should not be combined with  
 
radiotherapy to the axilla because of excess morbidity. Removal of the internal  
 
mammary lymph nodes is unnecessary. 
 
 
 
SENTINEL NODE BIOPSY 
 
This technique has become the standard of care in the management of the axilla  
 
in patients with clinically node-negative disease. The sentinel node is localised  
 
peroperatively by the injection of patent blue dye and radioisotope labelled 
 
albumin in the breast. The recommended site of injection is in the subdermal  
 
plexus around the nipple although some still inject on the axillary side of the  
 
cancer. The marker passes to the primary node draining the area and is detected 
 
visually and with a hand-held gamma camera. Peropererative diagnosis allows  
 
completion axillary clearance if nodal disease is detected. This may be achieved  
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with frozen-section analysis, touch imprint cytology (TIC) or by molecular  
 
methods. These involve homogenising the node and detection of a gene such as 
 
cytokeratin 19 or mammoglobin. In some cases there are only subcapsular  
 
micrometastases that are missed at frozen section. In patients in whom there is  
 
no tumour involvement of the sentinel node, further axillary dissection can be  
 
avoided. A nomogram outlining the chances of further axillary node positivity  
 
has been developed by the group at Memorial Sloan Kettering Hospital, 
 
New York. Recent trial results have called into question the utility of  
 
completion axillary clearance after a positive sentinel node has been detected  
 
but, at present, this remains controversial. 
 
 
RADIOTHERAPY 
 
 
Radiotherapy to the chest wall after mastectomy is indicated in selected patients  
 
in whom the risks of local recurrence are high. This includes patients with large  
 
tumours and those with large numbers of positive nodes or extensive  
 
lymphovascular invasion. There is some evidence that postoperative chest wall  
 
radiotherapy improves survival in women with node-positive breast cancer. 
 
It is conventional to combine conservative surgery with radiotherapy to the  
 
remaining breast tissue. Recurrence rates are too high for treatment by local  
 
excision alone except in special cases (small node-negative tumours of a special  
 
type). Trials are under way to investigate whether radiotherapy can be given 
 
intraoperatively at one sitting or as an accelerated postoperative course. This  
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would have considerable advantages in making conservative surgery available  
 
in areas where radiotherapy is not currently used. It would also relieve the  
 
burden of the current demand for radiotherapy, which accounts for up to 40 per  
 
cent of activity in some departments. 
 
 
CHEMOTHERAPY 
Chemotherapy using a first-generation regimen such as a six monthly cycle of  
 
cyclophosphamide, methotrexate and 5-fluorouracil (CMF) will achieve a 25  
 
per cent reduction in the risk of relapse over a 10- to 15-year period. It is  
 
important to understand that this 25 per cent reduction refers to the likelihood of 
 
an event happening. For example, a woman with a 96 per cent chance of  
 
survival at, say, five years only has a 4 per cent chance of death over this time  
 
and the absolute benefit from chemotherapy would be an increase in survival  
 
rate of 1 per cent, to 97 per cent. This would not be a sufficient gain to offset the  
 
side effects of this potentially toxic therapy. However, for a woman with a 60  
 
per cent chance of dying (40 per cent survival rate) a 25 per cent reduction in  
 
risk would increase her likelihood of survival to 55 per cent and thus treatment  
 
would be worthwhile. CMF is no longer considered adequate adjuvant  
 
chemotherapy and modern regimens include an anthracycline (doxorubicin or 
 
epirubicin) and the newer agents such as the taxanes. 
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Chemotherapy was once confined to premenopausal women with a poor  
 
prognosis (in whom its effects are likely to be the result, in part, of a chemical  
 
castration effect) but is being increasingly offered to postmenopausal women  
 
with poor prognosis disease as well. Chemotherapy may be considered in  
 
patients if other prognostic factors, such as tumour grade, imply a high risk of  
 
recurrence. The effect of combining hormone and chemotherapy is additive  
 
although hormone therapy is started after completion of chemotherapy to reduce 
 
side effects. High-dose chemotherapy with stem cell rescue for patients with  
 
heavy lymph node involvement has now been shown in controlled trials to offer  
 
no advantage and has been abandoned. 
 
 
Primary chemotherapy (neoadjuvant) is being used in many centres for large but  
 
operable tumours that would traditionally require a mastectomy (and almost  
 
certainly postoperative adjuvant chemotherapy). The aim of this treatment is to  
 
shrink the tumour to enable breast-conserving surgery to be performed. This  
 
approach is successful in up to 80 per cent of cases but is not associated with  
 
improvements in survival compared with conventionally timed chemotherapy.  
 
For older patients with breast cancers strongly positive for hormone receptors a  
 
similar effect can be seen with three months of endocrine treatment. 
 
 
Newer ‘biological’ agents will be used more frequently as molecular targets are  
 
identified – the first of these, trastuzamab (Herceptin), is active against tumours  
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containing the growth factor receptor c-erbB2. Other agents currently available  
 
include bevacizumab, a vascular growth factor receptor inhibitor, and lapitinab,  
 
an oral combined growth factor receptor inhibitor.  
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CA RECTUM AND ANAL CANAL : 
Adenocarcinoma of the colon and rectum is one of the most common 
cancers occurring in the western world. It occurs in both sexes but 
morecommon in men. Almost half of these tumours occur inthe rectum and 
almost three-quarters are within reach of the flexible sigmoidoscope (60 cm 
from the anal margin). 
 
Pathology 
 
Carcinoma of the colon or rectum is an adenocarcinoma with a fibrous stroma 
that may progress in different ways: 
 
• as an exophytic cauliflower-type of growth; 
• as an ulcerating lesion penetrating through the bowel wall; 
• as an annular constricting growth; 
• as a diffuse infiltrating tumour; 
• as the rare colloidal mucus-secreting tumour. 
 
Colorectal carcinoma metastasizes to regional lymph nodes and via the 
bloodstream to the liver. 
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OBSERVATION 
A total of 50 patients with clinically evident surface malignancies were studied. 
Out of the 50, 46 lesions proved to be malignant and 4 were benign. 
All lesions of the oral cavity were  correctly diagnosed by scrape/imprint 
method. 
 
There were 5 cases of Ca Rectum of which 2 were misinterpreted as benign by 
scrape/imprint method while biopsy turned out to be Adenocarcinoma and 1 
was benign lesion by all the three methods and two cases were malignant by all 
the three methods. 
 
There were 12 cases of cutaneous ulcers of which 2 were Benign and 10 were 
malignant by biopsy. But out of  the 10 lesions, 1 lesion was misinterpreted as 
inflammatory by cytology but was proven by biopsy as SCC. 
 
1 case of Soft tissue sarcoma Lt arm was proven by HPE as Pleomorphic 
Sarcoma but misdiagnosed as benign by scrape/imprint cytology. 
 
Out of the 6 Ca Breast cases, one  biopsy proven Invasive Ductal Carcinoma 
was missed by cytology. 
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2 cases of Secondaries neck were studied of which 1 biopsy proven 
inflammatory lesion was misinterpreted by imprint cytology as malignant, while 
scrape cytology showed no evidence of malignancy. 
 
There was discordance in biopsy proven 4 cases between imprint and scrape 
cytology of which 3 were cases of Ca oral cavity SCC shown to be dysplasia by 
Imprint but malignant cells positive by Scrape cytology and 1 case of Ca Breast 
IDC was reported as inflammatory in Imprint, malignancy by scrape cytology. 
 
Among 50 cases, histological subtypes were conclusive by either of the 
cytological methods in 43 cases. 
Scrape cytology was found to be more useful for ulcerative lesions. 
AGE DISTRIBUTION 
Age  Frequency  Percentage  
Below 40yrs 3 6.0 
41 to 50yrs 9 18.0 
51 to 60yrs 17 34.0 
61 to 70yrs 13 26.0 
71 to 80yrs 8 16.0 
Total 50 100.0 
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Number indicates number of patients affected by the disease 
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AGE AND CASE DISTRIBUTION
Ulcerated neck swellings
Cutaneous ulcers
Ulcerated CA Breast
Tongue
Buccal mucosa
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CASE DISTRIBUTION 
LESION No. of cases Malignant Benign False 
positive 
False negative 
Ca Oral 
cavity 
24 24 - - - 
Malignant 
Cutaneous 
ulcers 
12 10 2 - 1 
Ca Breast 6 6 - - 1 
Ca Rectum 5 4 1 - 1 
Ulcerated 
neck 
swellings 
2 1 1 1 - 
Soft tissue 
sarcoma 
1 1 - - 1 
TOTAL 50  46 4 1 4 
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 DISEASED NON DISEASED TOTAL 
TEST POSITIVE 42 1 43 
TEST 
NEGATIVE 
4 3 7 
TOTAL 46 4 50 
 
 
 
 
49%
25%
12%
10%
4%
0%
Ca oral cavity malignant cutaneous ulcers Ca Breast
Ca Rectum Ulcerated neck secondaries
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SENSITIVITY 
The sensitivity of a clinical test refers to the ability of the test to correctly 
identify those patients with the disease(True positives) 
Sensitivity of scrape/imprint cytology by this study – 91% 
SPECIFICITY 
The specificity of a clinical test refers to the ability of the test to correctly 
identify those patients without the disease(True negatives) 
Specificity of scrape/imprint cytology by this study – 75% 
SENSITIVITY 91% 
SPECIFICITY 75% 
POSITIVE PREDICTIVE VALUE 97% 
NEGATIVE PREDICTIVE VALUE 43% 
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TOTAL CASES 
 
CASES 
DETECTED 
BY 
IMPRINT 
CYTOLOGY 
CASES 
DETECTED 
BY SCRAPE 
CYTOLOGY 
BIOPSY 
 
MALIGNANT - 
46 
 
 
43 
  
42 
 
46 
 
BENIGN - 4 
 
 
 
3 
 
2 
 
4 
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RESULTS 
A total of 50 patients with clinically evident Surface malignancies were 
studied. Out of the 50, 46 lesions proved to be malignant and 4 were benign. 
All lesions of the oral cavity were  correctly diagnosed by scrape/imprint 
method. 
 
There were 5 cases of Ca Rectum of which 2 were misinterpreted as 
benign by scrape/imprint method while biopsy turned out to be 
Adenocarcinoma and 1 was benign lesion by all the three methods. 
 
There were 12 cases of Malignant cutaneous ulcers of which 2 were 
Benign and 10 malignant of which 1 lesion was misinterpreted as inflammatory 
but was proven by biopsy as SCC. 
 
1 case of Soft tissue sarcoma Lt arm was proven by HPE as Pleomorphic 
Sarcoma but misdiagnosed as benign by scrape/imprint cytology. 
Out of the 6 Ca Breast cases,1 biopsy proven Invasive Ductal Carcinoma was 
missed by cytology. 
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2 cases of ulcerated neck swellings were studied of which 1 biopsy 
proven inflammatory lesion was misinterpreted by imprint cytology as 
malignant, while scrape cytology showed no evidence of malignancy. 
 
There was discordance in 4 cases between imprint and scrape cytology of 
which 3 were cases of Ca oral cavity SCC shown to be dysplasia by Imprint but 
malignant cells positive by Scrape cytology and 1 case of Ca Breast IDC was 
reported as Benign in Imprint, malignancy by scrape cytology. Among 50 cases, 
histological subtype was conclusive by either of the cytological methods in 43 
cases. 
 
Scrape cytology was found to be more useful for ulcerative lesions. 
 
Totally there were 1 false positive and 4 false negative result. 
In 86% of cases exact cytopathological diagnosis was reached which correlated 
with HPE diagnosis. 
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DISCUSSION 
During the one year study period, 50 cases were examined of which 46 
were malignant i.e. 92%. Most common malignancy is oral cavity malignancy 
with males preponderance, followed by malignant cutaneous ulcers.  
 
In oral malignancies out of the 26 cases studied, predominant were Ca – buccal 
mucosa , owing to the common etiological factor – Tobacco chewing. Among 3 
biopsy proven cases of oral malignancies, imprint cytology reveals dysplasia 
but scrape cytology shows positive malignant cells. But by either one of the 
methods, the cytological diagnosis matched HPE results in all the cases. Hence 
in this study it is observed that establishing cytological diagnosis is more 
accurate in cases of oral malignancies. 
 
There were 12 cases of malignant cutaneous ulcers of which 2 were 
Benign and 10 were malignant. Out of which 1 lesion was misinterpreted as 
benign but was proven by biopsy as SCC. The commonest lesion that presented 
as malignant cutaneous ulcer was SCC Followed by malignant melanoma. 
 
Of the 6 biopsy proven Ca breast cases studied, 1 case was found to be 
benign by cytology. One discordance was observed between imprint 
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[inflammatory] and scrape [malignancy] cytology. Exact cyto-pathological 
diagnosis was made in half the cases. 
Of the 5 Ca rectum and anal canal cases studied, 2 cases were found to be 
malignant by all three methods. 3 cases were benign by cytology. Out of those 3 
cases, 2 turned out to be malignant by biopsy. 1 case was benign by all three 
methods. Cytological methods seem to be less helpful in the diagnosis of ca 
rectum. 
 
One case of pleomorphic sarcoma was misinterpreted as benign this 
shows that malignancies with excessive stromal components, cytology is 
inconclusive 
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CONCLUSION 
 Scrape/Imprint cytology is a rapid, safe, simple & inexpensive method to 
diagnose suspicious malignant lesion. 
 If scrape / imprint is positive, we can proceed with next level of 
management (surgery if needed) without waiting for biopsy report. 
 It can be done in resource poor conditions and promote early diagnosis 
and referral to specialist care. 
 Allays anxiety due to shorter waiting period and aids in quick decision 
making. 
 Highly sensitive, hence can be used as a rapid screening test. 
 Comparable to HPE reports in 86% of cases, hence can be used as 
valuable tool in PHCs & district hospitals 
 Minimal cellular distortion provides crisp cytological details. 
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LIST OF ABBREVIATIONS USED 
 
SCC Squamous Cell Carcinoma 
AC Adenocarcinoma 
MM Malignant Melanoma 
AM Amelanocytic Melanoma 
PS Pleomorphic Sarcoma 
STS Soft Tissue Sarcoma 
 
IDC Invasive Ductal Carcinoma 
MAL Smear positive for malignancy 
INF Inflammatory cells 
NEM No Evidence of Malignancy 
BEN Benign 
DYS Dysplasia 
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A B C D E F G H I J K L M N
S.NO AGE SEX CLINICAL DIAGNOSIS IMPRINT CYTOLOGY SCRAPE CYTOLOGY BIOPSY
1 49 M SCC Left Foot SCC SCC SCC
2 50 M Ca Rectum INF INF AC
3 39 M Ca Buccal mucosa SCC SCC SCC
4 47 M Ca Rectum/Recurrence MAL AC AC
5 55 F STS Left arm/Recurrence Spindle cell lesion inadequate PS
6 80 M Ca Lower Lip SCC SCC SCC
7 50 M Growth Lt Index finger SCC SCC SCC
8 50 F Ca Lt Breast MAL IDC IDC
9 55 M SCC Left Foot INF INF SCC
10 33 F Ca Rectum ?POLYP/BEN INF AC
11 60 F Ca Rt Breast INF MAL IDC
12 60 F Ca Lt Breast IDC IDC IDC
13 70 M AM Lt Arm MM MM CARCINOSARCOMA
14 55 M Ca Lip MAL MAL SCC 
15 56 M Ca Lt Buccal mucosa MAL MAL SCC
16 55 M Ca Lip MAL MAL SCC
17 64 M SCC Rt Foot MAL SCC SCC
18 55 M Ca Rt Buccal mucosa DYS MAL SCC
19 45 M Ca Rt Buccal mucosa DYS SCC SCC
20 50 M Ca Rt Buccal mucosa SCC MAL SCC
21 63 M Ca Rt Buccal mucosa DYS SCC SCC
22 72 M MM Rt Foot MAL MAL MM
23 65 M Ca Lt Buccal mucosa SCC SCC SCC
24 65 M Ca Rt Buccal mucosa SCC SCC SCC
25 75 M Ca Rt RMT DYS SCC SCC
26 70 F Ca Lower Lip SCC SCC SCC
27 55 F Ca Lip MAL SCC SCC
28 52 M Secondaries neck SCC INF SCC
29 61 M Ca Rectum AC AC AC
30 71 M Ca Lower Lip SCC SCC SCC
31 67 M Marjolins Ulcer BEN INF INF
32 60 F Ca Rt Buccal mucosa SCC SCC SCC
33 62 M Ca Rt Buccal mucosa SCC MAL SCC
34 62 M MM Lt Foot MAL MAL MM
35 64 M Secondaries neck SCC INF INF
36 54 F Ca Lower Lip MAL SCC SCC
37 75 M Ca Lower Lip SCC SCC SCC
38 74 M Ca RMT MAL SCC SCC
39 62 M SCC Rt Foot MAL SCC SCC
40 65 M Ca Rt Buccal mucosa SCC SCC SCC
41 60 M Marjolins Ulcer BEN INF ULCER with granulation tissue
42 58 M Ca Lt Buccal mucosa SCC SCC SCC
43 48 F Ca Rt Breast MAL IDC IDC
44 72 F Ca Lt Breast NEM NEM IDC
45 46 M AM Lt Arm MM MM MM
46 72 F Ca Tongue SCC SCC SCC
47 60 F Ca Rt Breast MAL MAL IDC
48 52 M SCC Rt Middle Finger SCC SCC SCC
49 60 M Ca Rectum NEM NEM NEM
50 40 M Ca Lt Buccal mucosa SCC SCC SCC
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ULCER with granulation tissue
